ATE380545T1 - Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung - Google Patents

Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung

Info

Publication number: ATE380545T1
Authority: AT; Austria
Prior art keywords: active ingredients; oral administration; pharmaceutical preparation; delayed release; release pharmaceutical
Prior art date: 2002-10-23

Application number

AT03014596T

Other languages

English (en)

Inventor

Jong-Soo Woo

Moon-Hyuk Chi

Original Assignee

Hanmi Pharm Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-23

Filing date

2003-07-08

Publication date

2007-12-15

2003-07-08 Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd

2007-12-15 Application granted granted Critical

2007-12-15 Publication of ATE380545T1 publication Critical patent/ATE380545T1/de

Links

239000004480 active ingredient Substances 0.000 title 1
230000003111 delayed effect Effects 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000036571 hydration Effects 0.000 abstract 1
238000006703 hydration reaction Methods 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Neurology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT03014596T 2002-10-23 2003-07-08 Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung ATE380545T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR1020020064940A KR100548925B1 (ko)	2002-10-23	2002-10-23	약물의 경구투여용 서방성 조성물

Publications (1)

Publication Number	Publication Date
ATE380545T1 true ATE380545T1 (de)	2007-12-15

Family

ID=36093911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03014596T ATE380545T1 (de)	2002-10-23	2003-07-08	Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung

Country Status (19)

Country	Link
US (1)	US7704526B2 (de)
EP (1)	EP1413295B1 (de)
JP (1)	JP4177227B2 (de)
KR (1)	KR100548925B1 (de)
CN (1)	CN100342912C (de)
AT (1)	ATE380545T1 (de)
AU (1)	AU2003272118B2 (de)
BR (1)	BR0315604A (de)
CA (1)	CA2502731C (de)
DE (1)	DE60317993T2 (de)
ES (1)	ES2297078T3 (de)
IL (1)	IL167725A (de)
MX (1)	MXPA05004018A (de)
NZ (1)	NZ539192A (de)
PL (1)	PL375440A1 (de)
RU (1)	RU2295358C2 (de)
UA (1)	UA77123C2 (de)
WO (1)	WO2004037290A1 (de)
ZA (1)	ZA200503270B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100598326B1 (ko) *	2004-04-10	2006-07-10	한미약품 주식회사	ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
KR100620241B1 (ko) *	2004-10-21	2006-09-19	한국유나이티드제약 주식회사	벤라팍신 염산염의 장기지속성 경구투여 조성물
WO2006129966A1 (en) *	2005-05-31	2006-12-07	Ctc Bio, Inc.	Manufacturing method of controlled-release tablet containing doxazocin mesylate
WO2007055329A1 (ja) *	2005-11-11	2007-05-18	Asahi Kasei Chemicals Corporation	徐放性固形製剤
ES2624003T3 (es) *	2005-12-27	2017-07-12	Monosol Rx, Llc	Películas de pH modulado para el suministro de principios activos
CN101129355B (zh) *	2007-08-03	2010-12-08	山东华信制药有限公司	一种洛伐他汀缓释片及其制备方法
RU2363464C2 (ru) *	2007-09-18	2009-08-10	Закрытое Акционерное Общество "Канонфарма Продакшн"	Таблетированная лекарственная форма фелодипина с модифицированным высвобождением, способ ее получения, композиция для ее изготовления и медицинское применение
US20100159001A1 (en) *	2008-12-19	2010-06-24	Cardinal John R	Extended-Release Pharmaceutical Formulations
PL226261B1 (pl) *	2008-12-31	2017-07-31	Univ Jagiellonski	Kompozycja do przedłużonego uwalniania heparyny i zastosowanie żelu alginian-hydroksypropyloceluloza do przedłużonego uwalniania heparyny
JP6191883B2 (ja) *	2011-08-16	2017-09-06	カーディオラピーティーワイリミテッド	制御放出製剤
CN102349880B (zh) *	2011-10-12	2015-07-22	合肥华方医药科技有限公司	伊拉地平控释片及其制备方法
RU2554815C1 (ru) *	2014-06-18	2015-06-27	Общество с ограниченной ответственностью "Нанолек"	Гипотензивное средство
KR20170098897A (ko)	2014-12-22	2017-08-30	카디오라 피티와이 엘티디	치료 방법
JP7390695B2 (ja) *	2017-02-03	2023-12-04	株式会社東洋新薬	錠剤及び錠剤の製造方法
CN107050419A (zh) *	2017-04-20	2017-08-18	上药东英（江苏）药业有限公司	一种培哚普利及其盐的渗透泵片及其制备方法
EP3501503A1 (de) *	2017-12-22	2019-06-26	Cosmo Technologies Ltd.	Feste verabreichungszusammensetzung
CN109288808A (zh) *	2018-11-13	2019-02-01	华东理工大学	一种溶出度高的植物纤维素胶囊

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4765984A (en) *	1986-01-22	1988-08-23	Colgate-Palmolive Company	Stable single unit dose oral product
US4792452A (en)	1987-07-28	1988-12-20	E. R. Squibb & Sons, Inc.	Controlled release formulation
US5128143A (en) *	1988-09-19	1992-07-07	Edward Mendell Co., Inc.	Sustained release excipient and tablet formulation
US5415872A (en) *	1992-06-22	1995-05-16	Digestive Care Inc.	Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
AU772891B2 (en) *	1998-12-11	2004-05-13	Nostrum Pharmaceuticals, Inc.	Sustained release tablet containing hydrocolloid and cellulose ether
EP1142565A4 (de) *	1999-10-20	2004-03-17	Teijin Ltd	Wässerige arzneimittel
US6264981B1 (en) *	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
DE60112073T2 (de) *	2000-05-12	2006-04-20	Pharmacia & Upjohn Co. Llc, Kalamazoo	Impfstoffzusammensetzung und verfahren zur herstellung derselben sowie verfahren zur impfung von wirbeltieren
US6465014B1 (en) *	2001-03-21	2002-10-15	Isp Investments Inc.	pH-dependent sustained release, drug-delivery composition

2002
- 2002-10-23 KR KR1020020064940A patent/KR100548925B1/ko not_active Expired - Fee Related
2003
- 2003-07-08 EP EP03014596A patent/EP1413295B1/de not_active Expired - Lifetime
- 2003-07-08 ES ES03014596T patent/ES2297078T3/es not_active Expired - Lifetime
- 2003-07-08 DE DE60317993T patent/DE60317993T2/de not_active Expired - Lifetime
- 2003-07-08 AT AT03014596T patent/ATE380545T1/de not_active IP Right Cessation
- 2003-08-27 US US10/650,931 patent/US7704526B2/en not_active Expired - Fee Related
- 2003-10-23 JP JP2003362832A patent/JP4177227B2/ja not_active Expired - Fee Related
- 2003-10-23 UA UAA200504799A patent/UA77123C2/uk unknown
- 2003-10-23 WO PCT/KR2003/002241 patent/WO2004037290A1/en not_active Ceased
- 2003-10-23 BR BR0315604-4A patent/BR0315604A/pt not_active IP Right Cessation
- 2003-10-23 NZ NZ539192A patent/NZ539192A/en not_active IP Right Cessation
- 2003-10-23 AU AU2003272118A patent/AU2003272118B2/en not_active Ceased
- 2003-10-23 MX MXPA05004018A patent/MXPA05004018A/es active IP Right Grant
- 2003-10-23 CA CA002502731A patent/CA2502731C/en not_active Expired - Fee Related
- 2003-10-23 RU RU2005115483/15A patent/RU2295358C2/ru not_active IP Right Cessation
- 2003-10-23 PL PL03375440A patent/PL375440A1/xx not_active IP Right Cessation
- 2003-10-23 CN CNB2003801017349A patent/CN100342912C/zh not_active Expired - Fee Related
2005
- 2005-03-29 IL IL167725A patent/IL167725A/en not_active IP Right Cessation
- 2005-04-22 ZA ZA200503270A patent/ZA200503270B/en unknown

Also Published As

Publication number	Publication date
US7704526B2 (en)	2010-04-27
RU2295358C2 (ru)	2007-03-20
ZA200503270B (en)	2006-10-25
JP4177227B2 (ja)	2008-11-05
US20040081693A1 (en)	2004-04-29
KR20040036130A (ko)	2004-04-30
AU2003272118B2 (en)	2007-03-08
RU2005115483A (ru)	2005-11-20
BR0315604A (pt)	2005-08-23
CN100342912C (zh)	2007-10-17
IL167725A (en)	2010-05-31
CA2502731A1 (en)	2004-05-06
DE60317993D1 (de)	2008-01-24
DE60317993T2 (de)	2008-04-17
CN1741819A (zh)	2006-03-01
MXPA05004018A (es)	2007-08-30
AU2003272118A1 (en)	2004-05-13
EP1413295A1 (de)	2004-04-28
ES2297078T3 (es)	2008-05-01
WO2004037290A1 (en)	2004-05-06
JP2004143175A (ja)	2004-05-20
NZ539192A (en)	2006-11-30
UA77123C2 (en)	2006-10-16
EP1413295B1 (de)	2007-12-12
CA2502731C (en)	2009-03-17
PL375440A1 (en)	2005-11-28
KR100548925B1 (ko)	2006-02-02

Legal Events

Date	Code	Title	Description
2008-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE380545T1 (de)	2007-12-15	Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung
AR023972A1 (es)	2002-09-04	Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
ATE450252T1 (de)	2009-12-15	Arzneimittel-mikroteilchen
HUP0101237A1 (hu)	2001-09-28	Elnyújtott kioldódású gyógyszerkészítmények
NO993520D0 (no)	1999-07-16	Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
ATE504288T1 (de)	2011-04-15	Oros-push-stick für die kontrollierte abgabe von wirkstoffen
EA200600598A1 (ru)	2006-08-25	Лекарственные формы замедленного высвобождения
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
NO20043871L (no)	2004-09-15	Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
WO2007012019A3 (en)	2007-11-01	Medicaments containing famotidine and ibuprofen and administration of same
DE69521688D1 (de)	2001-08-16	Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
ATE541562T1 (de)	2012-02-15	Ibuprofen-suspension
JP2010518086A5 (de)	2011-03-31
DE60124294D1 (de)	2006-12-14	Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
NO20023551D0 (no)	2002-07-25	Ibuprofen-inneholdende aktivt middel-preparat
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
ATE262893T1 (de)	2004-04-15	Darreichungsformen zur behandlung von oralen mykosen
AU2002214389A1 (en)	2002-04-22	Pharmaceutical composition containing honey for the treatment of wounds
ATE531361T1 (de)	2011-11-15	Neue pharmazeutische dosierform und herstellungsverfahren
ATE304844T1 (de)	2005-10-15	Entzündungshemmende pharmazeutische formulierungen
EA200701409A1 (ru)	2007-10-26	Новая композиция
BR0311141A (pt)	2005-06-07	Interação sinergìstica de abacavir e alovudine
DE50311479D1 (de)	2009-06-10	Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
MY145885A (en)	2012-05-15	Controlled release formulations for oral administration